Specialist nurse management programmes: Economic benefits in the management of heart failure

PharmacoEconomics

Volumn 21, Issue 4, 2003, Pages 225-240

  Stewart, Simon ^a   Horowitz, John D ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

AUSTRALIA; CAUSE OF DEATH; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG COST; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; META ANALYSIS; NURSE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; GREAT BRITAIN; HEALTH CARE COSTS; HEART FAILURE, CONGESTIVE; HOME CARE SERVICES; HUMANS; RANDOMIZED CONTROLLED TRIALS; SPECIALTIES, NURSING; TIME FACTORS;

EID: 0037226190     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200321040-00001     Document Type: Review

References (99)

1. Garg R, Packer M, Pitt B, et al. Heart failure in the 1990's: evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol 1993; 22: 3A-5A
2. Adams KF. New epidemiologic perspectives concerning mild-to-moderate heart failure. Am J Med 2001; 110 Suppl 7A: 6S-13S
3. Capewell S, MacIntyre K, Stewart S, et al. Age, sex and social trends in out-of-hospital cardiac deaths in Scotland 1986-1995: a retrospective cohort study. Lancet 2001; 358: 1213-7
4. Capewell S, Livingston BM, MacIntyre K, et al. Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J 2000; 21: 1833-40
5. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10 year results from 37 WHO MONICA Project populations. Lancet 1999; 353: 1547-57
6. MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure: trends in case-fatality in 66,547 patients hospitalised between 1986 and 1995. Circulation 2000; 102: 1126-31
7. Stewart S, MacIntyre K, McCleod MC, et al. Trends in heart failure hospitalisations in Scotland, 1990-1996: an epidemic that has reached its peak? Eur Heart J 2000; 22: 209-17
8. Stewart S, MacIntyre K, Capewell S, et al. Heart failure and the aging population: an increasing burden in the 21[st] century? Heart 2003; 89: 49-53
9. Kelly DT. Our future society: a global challenge. Circulation 1997; 95: 2459-64
10. Bonneux L, Barendregt JJ, Meeter K, et al. Estimating clinical morbidity due to ischaemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health 1994; 84: 20-8
11. Mosterd A, Reitsma JB, Grobbee DE. ACE inhibition and hospitalisation rates for heart failure in The Netherlands, 1980-1998: the end of an epidemic? Heart 2002; 87: 75-6
12. Cleland JG, Gemmell I, Khand A, et al. Is the prognosis of heart failure improving? Eur J Heart Fail 1999; 1: 229-41
13. Haldeman GA, Croft JB, Giles WH, et al. Hospitalization of patients with heart failure: national hospital discharge survey 1985-1995. Am Heart J 1999; 137: 352-60
14. Eriksson H, Wilhelmsen L, Caidahl K, et al. Epidemiology and prognosis of heart failure. Z Kardiol 1991; 80: 1-6
15. Doughty R, Yee T, Sharpe N, et al. Hospital admissions and deaths due to congestive heart failure in New Zealand, 1988-91. N Z Med J 1995; 108: 473-5
16. Reitsma JB, Mosterd A, de Craen AJM, et al. Increase in hospital admission rates for heart failure in the Netherlands, 1980-1993. Heart 1996; 76: 388-92
17. Rydén-Bergsten T, Andersson F. The health care costs of heart failure in Sweden. J Intern Med 1999; 246: 275-84
18. McMurray JJV, Hart W, Rhodes G. An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Med Econ 1993; 6: 91-8
19. Stewart S, Jenkins A, Buchan S, et al. The current cost of heart failure in the UK: an economic analysis. Eur J Heart Fail 2002; 4: 361-71
20. Petrie MC, Dawson NF, Murdoch DR, et al. Failure of women's hearts. Circulation 1999; 99: 2334-41
21. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002; 162: 1682-8
22. MacDowall P, Kaira P, O'Donoghue D, et al. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 1998; 352: 13-6
23. Berry C, McMurray J. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone. Am J Med 2001; 111: 587
24. Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation 1999; 100: 2312-8
25. CIBIS II Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomised trial. Lancet 1999; 353: 9-13
26. Packer M, Coats AJS, Fowler MB, et al., for the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-8
27. The RALES Investigators. Effectiveness of spirinolactone added to an angiotensin-converting enzyme inhibitor and a loop-diuretic for severe chronic congestive heart failure. Am J Cardiol 1996; 78: 902-7
28. CIBIS-II Investigators and Health Economics Group. Reduced costs with bisoprolol treatment for heart failure: an economic analysis of the second cardiac insufficiency bisoprolol study (CIBIS-II). Ear Heart J 2001; 22: 1021-31
29. Stewart S, McMurray JJV, Hebborn A, et al. Carvedilol reduces the cost of medical care in severe heart failure: an economic analysis of the COPERNICUS Study applied to the United Kingdom. Circulation 2001; 104: II-717
30. Hummel S, Piercy J, Wright R, et al. An economic analysis of the Survival and Ventricular Enlargement (SAVE) Study. Pharmacoeconomics 1997; 12 (2 Pt 1): 182-92
31. Stewart S, MacIntyre K, Hole DA, et al. More malignant than cancer?: five-year survival following a first admission for heart failure in Scotland? Eur J Heart Fail 2001; 3: 315-22
32. Cowie MR, Wood DA, Coats AJS, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 2001; 83: 505-10
33. Juenger J, Schellberg D, Kraemer S, et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002; 87: 235-41
34. Cowie MR, Fox KF, Wood DA, et al. Hospitalization of patients with heart failure: a population-based study. Eur Heart J 2002; 23: 842-5
35. Levenson JW, McCarthy EP, Lynn J, et al. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 2000; 48: S101-9
36. Vaccarino V, Kasl SV, Abramson J, et al. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001; 38: 199-205
37. Jaagosild P, Dawson NV, Thomas C, et al. Outcomes of acute exacerbation of severe congestive heart failure: quality of life, resource use, and survival. SUPPORT Investigators: the Study to Understand Prognosis and Preferences for Outcomes and Risks of Treatments. Arch Intern Med 1998; 158: 1081-9
38. Mark DB. Economics of treating heart failure. Am J Cardiol 1997; 80: 33H-8H
39. Weintraub WS, Cole J, Tooley JF. Cost and cost-effectiveness studies in heart failure research. Am Heart J 2002; 143: 565-76
40. Rich MW, Nease RF. Cost-effectiveness analysis in clinical practice: the case of heart failure. Arch Intern Med 1999; 159: 1690-700
41. Ahmed A. Quality and outcomes of heart failure care in older adults: role of multidisciplinary disease-management programmes. J Am Geriatr Soc 2002; 50: 1590-3
42. McAlister FA, Lawson FM, Teo KK, et al. A systematic review of randomized trials of disease management programmes in heart failure. Am J Med 2001; 110: 378-84
43. Rich MW. Heart failure disease management: a critical review. J Card Fail 1999; 5: 64-75
44. Philbin EF. Comprehensive multidisciplinary programmes for the management of patients with congestive heart failure. J Gen Intern Med 1999; 14: 130-5
45. McMurray JJV, Stewart S. Nurse-led multidisciplinary intervention in chronic heart failure [editorial]. Heart 1998; 80: 430-1
46. Horowitz JD. Home-based intervention: the next step in treatment of chronic heart failure? Eur Heart J 2000; 21: 1807-9
47. Erhardt L, Cline C. Heart failure clinics: a possible means of improving care. Heart 1998; 80: 428-9
48. Cline CM, Boman K, Holst M, et al. The management of heart failure in Sweden. Eur J Heart Fail 2002; 4: 373-6
49. Rich MW, Vinson JM, Sperry JC, et al. Prevention of readmission in elderly patients with congestive heart failure: results of a prospective, randomized pilot study. J Gen Intern Med 1993: 8: 585-90
50. Rich MW, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190-5
51. Cintron G, Bigas C, Linares E, et al. Nurse practitioner role in a chronic congestive heart failure clinic: in hospital time, costs and patient satisfaction. Heart Lung 1993; 12: 237-40
52. Naylor M, Brooten D, Jones R, et al. Comprehensive discharge planning for the hospitalized elderly. Ann Intern Med 1994; 120: 999-1006
53. Fitzgerald JF, Smith DM, Martin DK, et al. A case manager intervention to reduce readmissions. Arch Intern Med 1994; 154: 1721-9
54. Kornowski R, Zeeli D, Averbuch M, et al. Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J 1995; 129: 162-6
55. Lasater M. The effect of a nurse managed CHF clinic on patient readmission and length of stay. Home Healthc Nurse 1996; 14: 351-6
56. Roglieri J, Futterman R, McDonough KL, et al. Disease management interventions to improve outcomes in congestive heart failure. Am J Manag Care 1997; 3: 1831-9
57. Hanumanthu S, Butler J, Chomsky D, et al. Effect of a heart failure programme on hospitalization frequency and exercise tolerance. Circulation 1997; 96: 2842-8
58. West J, Miller N, Parker K, et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol 1997; 79: 58-63
59. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management programme on hospital readmissions and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997; 30: 725-32
60. Shah NB, Der E, Ruggerio C, et al. Prevention of hospitalizations for heart failure with an interactive home monitoring programme. Am Heart J 1998; 135: 373-8
61. Macko MJ. Evaluation of cost and hospitalization outcomes from a community case management programme serving heart failure clients [Abstract]. J Card Fail 1998; 4: 59
62. Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with chronic congestive heart failure. Arch Intern Med 1998; 158: 1067-72
63. Cline C, Israelsson B, Willenheimer R, et al. A cost effective management programme for heart failure reduces hospitalization. Heart 1998; 80: 442-6
64. Ekman I, Andersson B, Ehnfors M, et al. Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure. Eur Heart J 1998; 19: 1254-60
65. Oddone EZ, Weinberger M, Giobbie-Hurder A, et al. Enhanced access to primary care for patients with congestive heart failure: Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission. Eff Clin Pract 1999; 2: 201-9
66. Cordisco ME, Beniaminovitz A, Hammond K, et al. Use of telemonitoring to decrease the rate of hospitalization in patients with severe congestive heart failure. Am J Cardiol 1999; 84: 860-2
67. Stewart S, Vandenbroek A, Pearson S, et al. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among congestive heart failure patients. Arch Intern Med 1999; 159: 257-61
68. Gattis WA, Hasselblad V, Whellan DJ, et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med 1999; 159: 1939-45
69. Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomized controlled study. Lancet 1999; 354: 1077-83
70. Jaarsma T, Halfens R, Huijer Abu-Saad H, et al. Effects of education and support on self-care and resource utilization in patients with heart failure. Eur Heart J 1999; 20: 673-82
71. Naylor MD, Brooten D, Cambell R, et al. Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. JAMA 1999; 281: 613-20
72. Dahl J, Penque S. The effects of an advanced practice nurse-directed heart failure programme. Nurse Pract 2000; 25: 61-77
73. Moser DK, Macko MJ, Worster P. Community case management decreases rehospitalisation rates and costs, and improves quality of life in heart failure patients with preserved and non-preserved left ventricular function: a randomized controlled trial. Circulation 2000; 102: II 749
74. Jerant AF, Azari R, Nesbitt TS. Reducing the cost of frequent hospital admissions for congestive heart failure: a randomized trial of a home telecare intervention. Med Care 2001; 39: 1234-45
75. McDonald K, Ledwidge M, Cahill J, et al. Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzyme inhibitor dose at discharge. Eur J Heart Fail 2001; 3: 209-15
76. Holst DP, Kaye D, Richardson M, et al. Improved outcomes from a comprehensive management system for heart failure. Eur J Heart Fail 2001; 3: 619-25
77. Kasper EK, Gerstenblith G, Hefter G, et al. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol 2002; 39: 471-80
78. Stewart S, Horowitz JD. Home-based intervention in congestive heart failure: long-term implications on readmission and survival. Circulation 2002; 105: 2861-6
79. Riegel B, Carlson B, Kopp Z, et al. Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure. Arch Intern Med 2002; 162: 705-12
80. Harrison MB, Browne GB, Roberts J. Quality of life of individuals with heart failure: a randomized trial of the effectiveness of two models of hospital-to-home transition. Med Care 2002; 40: 271-82
81. Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 2002; 39: 83-9
82. Doughty RN, Wright SP, Walsh HJ, et al. Randomised, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study. Eur Heart J 2002; 23: 139-46
83. Blue L, Strong E, Murdoch DR, et al. Improving long-term outcome with specialist nurse intervention in heart failure: a randomized trial. BMJ 2002; 323: 1112-5
84. Petrie MC, Berry C, Stewart S, et al. Failing ageing hearts. Eur Heart J 2001; 22: 1978-90
85. Wolinsky F, Smith D, Stump T, et al. The sequele of hospitalization for congestive heart failure among older adults. J Am Geriatr Soc 1997; 45: 558-63
86. Burns RB, McCarthy EP, Moskowitz MA, et al. Outcomes for older men and women with congestive heart failure. J Am Geriatr Soc 1997; 45: 276-80
87. Stewart S, Pearson S, Luke CG, et al. Effects of a home based intervention on unplanned readmissions and out-of-hospital deaths. J Am Geriatr Soc 1998; 46: 174-80
88. Swedberg K, Kjekshus J, Snapinn S, et al. Long-term survival in severe heart failure in patients with enalapril. Eur Heart J 1999; 20: 136-9
89. Rich MW, Gray DB, Beckham V, et al. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 1996; 101: 270-6
90. Cline CM, Bjorck-Linne AK, Israelsson BY, et al. Non-compliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail 1999: 1: 145-9
91. Jaarsma T, Dracup K. Determinants of health care utilization by patients with chronic heart failure. In: Stewart S, Blue L, editors. Improving outcomes in chronic heart failure. London: BMJ Books, 2000
92. McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971; 285: 1441-6
93. Stewart S, Hart CL, Hole DJ, et al. The incidence and natural history of heart failure in 15,406 men and women over 20 years: the Renfrew/Paisley Study. Eur Heart J 2001; 22: 208
94. Stewart S, Blue L, Walker A, et al. An economic analysis of specialist heart failure nurse management in the UK: can we afford not to implement it? Eur Heart J 2002; 23: 1369-75
95. Blue L, McMurray JJV. A specialist, nurse-led, home-based intervention in Scotland. In: Stewart S, Blue L, editors. Improving outcomes in chronic heart failure. London: BMJ Books, 2000
96. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001; 22: 1527-60
97. UK National Health Service. National Health Service (UK) reference costs (2000). Available from URL: http://www.doh.gov.uk/nhsexec/refcosts/2000 [Accessed 2001 Jul]
98. Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999; 33: 1948-55
99. Senni M, Redfield MM. Heart failure with preserved systolic function: a different natural history? J Am Coll Cardiol 2001; 38: 1277-82